Daily Roundup

Austco Healthcare is on an acquisition spree, announcing two major deals in quick succession. The company plans to acquire RTM Solutions, a Brisbane-based software provider, for approximately $15.26 million in total consideration. RTM's real-time monitoring platform is already deployed across more than 600 sites in Australia, and the deal is expected to close around December 1, 2026. For Austco, this acquisition promises meaningful growth in software and recurring revenue, with RTM projected to contribute around $9.1 million in revenue and $1.3 million in EBITDA to the company in FY27.

In tandem, Austco is also acquiring CareTech Systems, a designer of nurse call products for aged care and smaller hospitals. The CareTech deal carries a lower price tag at $4.04 million in total consideration, but it fills an important gap in Austco's portfolio by adding lower-cost aged care systems and wireless products. Both acquisitions are structured to be immediately accretive to earnings per share and are inter-conditional, meaning they're tied together as part of a broader strategic push.

PLS Group has given the green light to a major expansion at its Pilgangoora lithium operation in Western Australia. The company approved the final investment decision for the P2000 Project, which will ramp up spodumene concentrate production to approximately 2 million tonnes per annum by the third quarter of 2029. The project is expected to deliver an incremental post-tax net present value of A$2.7 billion with an internal rate of return of 29.5%, based on a long-term spodumene concentrate price of US$1,620 per tonne.

The expansion is underpinned by a significant resource upgrade. PLS announced a 31% increase in contained lithium at Pilgangoora, with ore reserves climbing 23% to 249.2 million tonnes. The company also unveiled a maiden underground ore reserve of 46.5 million tonnes at 1.50% Li2O, which extends the mine's operating horizon to more than 25 years when combined with open pit operations.

To support this growth, PLS is investing A$600-650 million in infrastructure over three years through FY29. The investment includes upgrades to Wodgina Road East to enable higher-capacity haulage, reducing concentrate movements by roughly 35%, plus a new permanent village and mine services facility. These improvements are designed to reduce operating costs and boost productivity across the operation.

Ramsay Health Care is moving forward with its demerger plans. The Supreme Court of New South Wales has ordered a meeting for shareholders to vote on the demerger of Ramsay Santé, with voting scheduled for November 24, 2026. The Ramsay board unanimously recommends shareholders approve the resolutions, and independent expert Deloitte Corporate Finance has concluded that the demerger is in shareholders' best interests.

Mesoblast is firing on all cylinders, reporting a 44% increase in net revenue from its Ryoncil product in the quarter ending September 30, 2026. The company also achieved an impressive 85% improvement in net operating cash spend, demonstrating stronger operational discipline. With a robust cash position of $99 million as of September 30, Mesoblast is well-positioned to expand market penetration across its 54 onboarded sites while maintaining focus on commercial manufacturing and late-stage clinical programs.

Steadfast Group has disclosed receipt of a notice from Pentwater Capital Management LP under Australian Takeovers Panel Guidance Note 20 regarding equity derivatives. The disclosure was authorized by Steadfast's Disclosure Committee. Steadfast operates insurance broker and agency networks across Australia, New Zealand, Singapore, and the USA, placing approximately $26 billion in gross written premium annually.